Due to investments in research through the National Cancer Institute, rates of new cancers are declining. While AICR has funded more than $109 million for research in our own grant program, continued federal government investment in cancer research is key to ensuring a future without cancer.
Research funding from the National Institutes of Health (NIH) and, more specifically, the National Cancer Institute (NCI), made major contributions toward the strides taken against preventing and defeating cancer in the last decade. Even a small decrease in funding for these programs has the potential to derail this progress. AICR uses our voice and those of our researchers, both individually and as part of coalitions, to ensure that we continue on this path forward.
How We Are Taking Action
Coalitions Helping Us Achieve This Goal
- One Voice Against Cancer
In 2019, AICR joined One Voice Against Cancer (OVAC), a coalition of cancer-fighting organizations with the goal of increasing funding for federal cancer research programs.
- In 2019, we signed onto OVAC’s letter urging Congress to provide at least $42.1 billion for NIH, with a proportional $6.4 billion increase for NCI for FY 2020. NIH was eventually funded at $41.46 billion, with NCI receiving $6.44 billion, a success for cancer research.
- In 2020, we joined OVAC in asking for $44.7 billion for NIH in FY 2021, a $3 billion increase over 2020, with $6.9 billion for NCI.
- We have also supported the provision of $10 billion in emergency relief funding to offset the impact of the COVID-19 pandemic on biomedical research.
- The Ad Hoc Group for Medical Research
AICR joined the Ad Hoc Group for Medical Research in 2019 to help amplify our voice in advocating for increased federal funding for the NIH.
- In 2019, we signed onto the Ad Hoc Group’s letter urging Congress to pass the FY2020 spending bill, funding the NIH and ending a Continuing Resolution that had left many uncertain about the future of biomedical research.
- In 2020, we signed onto the Ad Hoc Group’s letter urging the allocation of emergency funding in the Senate HEALS Act to help offset challenges faced by researchers due to the Coronavirus pandemic.